Harmony Biosciences Holdings Inc — movimiento de fondos (NASDAQ:HRMY) | MetaTrader

Ver el calendario completo

Financials

Visión general Informes Estadísticas

Flujo de caja de las actividades operativas -2.98 M98.56 M144.47 M219.39 M219.82 M348.2 M 348.2 M Flujo de caja de las actividades de inversión -2 M-100.3 M-141.83 M-46.44 M-67.48 M-39.65 M -39.65 M Flujo de caja de las actividades financieras 209.16 M7.42 M6.84 M-105.55 M-11 M-9.05 M -9.05 M Flujo de caja libre -2.99 M98.26 M144.29 M219.07 M218.67 M347.89 M 347.89 M

Noticias

Harmony Biosciences Holdings, Inc. (HRMY) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript

Harmony Biosciences nombra a Glenn Reicin como director financiero

Harmony Biosciences nombra a Peter Anastasiou director de operaciones

BEAM's Q4 Loss Narrower Than Expected, Revenues Rise Y/Y

IOVA Beats on Q4 Earnings & Sales, Stock Soars on Pipeline Progress

RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up

Corcept's Q4 Earnings and Revenues Fall Short of Estimates

Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y

Apellis Q4 Loss Wider Than Expected, Revenues Decline Y/Y

UBS reduce precio objetivo de Harmony Biosciences por entrada anticipada de genérico

UBS recorta el precio objetivo de Harmony Biosciences por entrada anticipada de genérico de Wakix

UBS cuts Harmony Biosciences stock price target on earlier Wakix generic entry